Skip to main content
. 2019 Nov 3;33(6):2153–2160. doi: 10.21873/invivo.11717

Figure 3. Progression-free (PFS) (A) and overall (OS) (B) survival according to treatment modification. PFS and OS were shorter for patients with immediate treatment interruption compared to those with dose reduction and those without treatment modification, although the statistical difference was not significant. There was no difference in survival between the patients with dose reduction and those without treatment modification. CI: Confidence interval.

Figure 3